Marcus Koppitz,Benjamin Bader,Ulf Bömer,Bertolt Kreft,Philip Lienau,Tobias Marquardt,Stefan Prechtl,Gerhard Siemeister,Christof Wegscheid-Gerlach
申请号：
US13264627
公开号：
US20120128662A1
申请日:
2010.04.24
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to substituted imidazoquinoxaline compounds of general formula (I) as inhibitors of Mps-1 Kinase or TTK, and being active against inflammation and cancer.
